tertatolol has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herman, AG; Verbeuren, TJ | 1 |
Berlan, M; Crampes, F; De Glisezinski, I; Galitzky, J; Lafontan, M; Moro, C; Sengenes, C; Thalamas, C | 1 |
1 trial(s) available for tertatolol and cyclic gmp
Article | Year |
---|---|
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Blood Glucose; Cross-Over Studies; Cyclic GMP; Double-Blind Method; Epinephrine; Exercise; Exercise Test; Extracellular Fluid; Fatty Acids, Nonesterified; Glycerol; Guanylate Cyclase; Humans; Isoproterenol; Lipolysis; Male; Microdialysis; Norepinephrine; Oxygen Consumption; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Receptors, Atrial Natriuretic Factor; Subcutaneous Tissue; Sympathetic Nervous System; Thiophenes | 2004 |
1 other study(ies) available for tertatolol and cyclic gmp
Article | Year |
---|---|
Pharmacological features of the vasodilation induced by tertatolol in isolated perfused rat kidneys.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Endothelium, Vascular; Kidney; Microcirculation; Propanolamines; Rats; Renal Circulation; Thiophenes; Vasodilation | 1989 |